Literature DB >> 35426938

Multi-omics Profiling Shows BAP1 Loss Is Associated with Upregulated Cell Adhesion Molecules in Uveal Melanoma.

Usman Baqai1, Timothy J Purwin1, Nelisa Bechtel1, Vivian Chua1, Anna Han1,2, Edward J Hartsough3, Jeffim N Kuznetsoff4,5, J William Harbour6, Andrew E Aplin1,7.   

Abstract

BRCA1-associated protein 1 (BAP1) is a tumor suppressor gene that is mutated in cancer, including uveal melanoma. Loss-of-function BAP1 mutations are associated with uveal melanoma metastasis and poor prognosis, but the mechanisms underlying these effects remain unclear. Upregulation of cell-cell adhesion proteins is involved with collective migration and metastatic seeding of cancer cells. Here, we show that BAP1 loss in uveal melanoma patient samples is associated with upregulated gene expression of multiple cell adhesion molecules (CAM), including E-cadherin (CDH1), cell adhesion molecule 1 (CADM1), and syndecan-2 (SDC2). Similar findings were observed in uveal melanoma cell lines and single-cell RNA-sequencing data from uveal melanoma patient samples. BAP1 reexpression in uveal melanoma cells reduced E-cadherin and CADM1 levels. Functionally, knockdown of E-cadherin decreased spheroid cluster formation and knockdown of CADM1 decreased growth of BAP1-mutant uveal melanoma cells. Together, our findings demonstrate that BAP1 regulates the expression of CAMs which may regulate metastatic traits. IMPLICATIONS: BAP1 mutations and increased metastasis may be due to upregulation of CAMs. ©2022 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 35426938      PMCID: PMC9357204          DOI: 10.1158/1541-7786.MCR-21-0657

Source DB:  PubMed          Journal:  Mol Cancer Res        ISSN: 1541-7786            Impact factor:   6.333


  71 in total

1.  KEGG: kyoto encyclopedia of genes and genomes.

Authors:  M Kanehisa; S Goto
Journal:  Nucleic Acids Res       Date:  2000-01-01       Impact factor: 16.971

2.  Comprehensive Integration of Single-Cell Data.

Authors:  Tim Stuart; Andrew Butler; Paul Hoffman; Christoph Hafemeister; Efthymia Papalexi; William M Mauck; Yuhan Hao; Marlon Stoeckius; Peter Smibert; Rahul Satija
Journal:  Cell       Date:  2019-06-06       Impact factor: 41.582

3.  Uveal melanoma driver mutations in GNAQ/11 yield numerous changes in melanocyte biology.

Authors:  Dahlia E Perez; Andrea M Henle; Adam Amsterdam; Hannah R Hagen; Jacqueline A Lees
Journal:  Pigment Cell Melanoma Res       Date:  2018-04-06       Impact factor: 4.693

4.  Functional gene expression analysis uncovers phenotypic switch in aggressive uveal melanomas.

Authors:  Michael D Onken; Justis P Ehlers; Lori A Worley; Jun Makita; Yoshifumi Yokota; J William Harbour
Journal:  Cancer Res       Date:  2006-05-01       Impact factor: 12.701

Review 5.  Molecular pathways mediating liver metastasis in patients with uveal melanoma.

Authors:  Silvin Bakalian; Jean-Claude Marshall; Patrick Logan; Dana Faingold; Shawn Maloney; Sebastian Di Cesare; Claudia Martins; Bruno F Fernandes; Miguel N Burnier
Journal:  Clin Cancer Res       Date:  2008-02-15       Impact factor: 12.531

6.  Patient-derived xenografts recapitulate molecular features of human uveal melanomas.

Authors:  Cécile Laurent; David Gentien; Sophie Piperno-Neumann; Fariba Némati; André Nicolas; Bruno Tesson; Laurence Desjardins; Pascale Mariani; Audrey Rapinat; Xavier Sastre-Garau; Jérôme Couturier; Philippe Hupé; Leanne de Koning; Thierry Dubois; Sergio Roman-Roman; Marc-Henri Stern; Emmanuel Barillot; J William Harbour; Simon Saule; Didier Decaudin
Journal:  Mol Oncol       Date:  2013-02-26       Impact factor: 6.603

7.  Cell-of-Origin Patterns Dominate the Molecular Classification of 10,000 Tumors from 33 Types of Cancer.

Authors:  Katherine A Hoadley; Christina Yau; Toshinori Hinoue; Denise M Wolf; Alexander J Lazar; Esther Drill; Ronglai Shen; Alison M Taylor; Andrew D Cherniack; Vésteinn Thorsson; Rehan Akbani; Reanne Bowlby; Christopher K Wong; Maciej Wiznerowicz; Francisco Sanchez-Vega; A Gordon Robertson; Barbara G Schneider; Michael S Lawrence; Houtan Noushmehr; Tathiane M Malta; Joshua M Stuart; Christopher C Benz; Peter W Laird
Journal:  Cell       Date:  2018-04-05       Impact factor: 41.582

8.  BAP1 and YY1 regulate expression of death receptors in malignant pleural mesothelioma.

Authors:  Yuki Ishii; Krishna K Kolluri; Adam Pennycuick; Xidan Zhang; Ersilia Nigro; Doraid Alrifai; Elaine Borg; Mary Falzon; Khalid Shah; Neelam Kumar; Sam M Janes
Journal:  J Biol Chem       Date:  2021-09-29       Impact factor: 5.157

9.  Circulating tumor cell clusters are oligoclonal precursors of breast cancer metastasis.

Authors:  Nicola Aceto; Aditya Bardia; David T Miyamoto; Maria C Donaldson; Ben S Wittner; Joel A Spencer; Min Yu; Adam Pely; Amanda Engstrom; Huili Zhu; Brian W Brannigan; Ravi Kapur; Shannon L Stott; Toshi Shioda; Sridhar Ramaswamy; David T Ting; Charles P Lin; Mehmet Toner; Daniel A Haber; Shyamala Maheswaran
Journal:  Cell       Date:  2014-08-28       Impact factor: 41.582

10.  BAP1 links metabolic regulation of ferroptosis to tumour suppression.

Authors:  Yilei Zhang; Jiejun Shi; Xiaoguang Liu; Li Feng; Zihua Gong; Pranavi Koppula; Kapil Sirohi; Xu Li; Yongkun Wei; Hyemin Lee; Li Zhuang; Gang Chen; Zhen-Dong Xiao; Mien-Chie Hung; Junjie Chen; Peng Huang; Wei Li; Boyi Gan
Journal:  Nat Cell Biol       Date:  2018-09-10       Impact factor: 28.824

View more
  1 in total

1.  Integrated multi-omics analyses reveal that BCAM is associated with epigenetic modification and tumor microenvironment subtypes of clear cell renal cell carcinoma.

Authors:  Junjie Zhao; Jiayu Liang; Yang Yang; Guangxi Sun; Xingming Zhang; Jinge Zhao; Xu Hu; Junru Chen; Sha Zhu; Yuchao Ni; Yaowen Zhang; Jindong Dai; Zhipeng Wang; Zilin Wang; Yuhao Zeng; Jin Yao; Ni Chen; Pengfei Shen; Zhenhua Liu; Hao Zeng
Journal:  Clin Epigenetics       Date:  2022-08-08       Impact factor: 7.259

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.